ArticleJournal of medicinal chemistry2024

Discovery of ZLC491 as a Potent, Selective, and Orally Bioavailable CDK12/13 PROTAC Degrader.

Licheng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.